Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?
Pediatric Blood & Cancer · 2026-07 · 73 (7)
DOI: 10.1002/1545-5017.70324 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 15.04.2026. Verfasst von Suzanne Tugnait und 23 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Biology & Cancer Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, …. Hauptthemen laut MEDLINE: Wilms Tumor, Kidney Neoplasms, Guideline Adherence, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pan-London Cancer Alliance Research Fellowship Programme, Pan-London Cancer Alliance, Little Princess Trust.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Methods
Retrospective analysis of risk‐stratified chemotherapy and radiotherapy regimens given to children with unilateral WT treated with pre‐operative chemotherapy in the SIOPWT2001 (2002–2011) and Improving Population Outcomes for Renal Tumours of Childhood (IMPORT) (2012–2018) studies in the United Kingdom and Ireland. Pre‐ and post‐operative treatments were classified as per protocol (PP), deviation (PDEV)—variation for specified clinical reasons, violation (PVIOL)—not treated PP.
Results
A total of 1256 children with WT were registered by 20 centres. A total of 1052 (84%) had unilateral WT treated with pre‐operative chemotherapy. All had centrally reviewed pathology. Case report forms allowing categorisation of the whole treatment pathway were available for 756 (72%) patients. Treatment was classified as PP in 452 (60%), PDEV in 175 (23%) and PVIOL in 129 (17%). Stage III/IV tumours had higher proportion PVIOL (21% and 35%, respectively) compared to Stage I/II tumours (8%–10%). Two‐thirds of patients were treated in ‘high‐volume’ centres (≥5 new WTs/year). Protocol adherence rates were similar between high‐ and low‐volume centres. Protocol adherence category had no impact on event‐free or OS.
Conclusions
Protocol guidelines are followed closely for lower stage tumours, but there is greater variation in advanced disease. Centre size showed no association with survival, emphasising the effectiveness of using a national treatment protocol, supported by central pathology review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Developmental Biology & Cancer Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
- Directorate of Medicines, Therapies and Test, Great Ormond Street Hospital, London, UK.
- Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Visceral Paediatric and Neonatal Surgery, Sorbonne Universite, Hôpital Armand Trousseau-APHP, Paris, France.
- Lung and Heart Institute, Imperial College, London, UK.
- Paediatric Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Förderung
- Pan-London Cancer Alliance Research Fellowship Programme
- Pan-London Cancer Alliance
- Little Princess Trust
- Children's Cancer and Leukaemia Group
Zitieren
APA
Tugnait, S., Al-Saadi, R., Lopez-Cortes, A., Dzhuma, K., Oostveen, M., Brok, J., Irtan, S., Weeks, M., Bate, J., Baker, S., Williams, R., Powis, M., Saunders, D., Olsen, O., Watson, T., Shelmerdine, S., Vaidya, S., Howell, L., Duncan, C., …, & Pritchard-Jones, K. (2026). Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?. Pediatric Blood & Cancer, 73(7). https://doi.org/10.1002/1545-5017.70324
Vancouver
Tugnait S, Al-Saadi R, Lopez-Cortes A, Dzhuma K, Oostveen M, Brok J, et al. Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?. Pediatric Blood & Cancer. 2026;73(7). doi:10.1002/1545-5017.70324
BibTeX
@article{Tugnait2026,
author = {Tugnait, Suzanne and Al-Saadi, R and Lopez-Cortes, A and Dzhuma, K and Oostveen, M and Brok, J and Irtan, S and Weeks, M and Bate, J and Baker, S and Williams, R and Powis, M and Saunders, D and Olsen, O and Watson, T and Shelmerdine, S and Vaidya, S and Howell, L and Duncan, C and Vujanic, G M and Stiller, C and Balchin, G P and Chowdhury, T and Pritchard-Jones, K},
title = {Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?},
journal = {Pediatric Blood & Cancer},
year = {2026},
volume = {73},
number = {7},
doi = {10.1002/1545-5017.70324}
}
EUVIMED